The effect of varying concentrations (0 -52 mg/1) of purified thyroxine binding globulin (TBG) on the microencapsulated antibody method for free thyroxine was investigated. The results demonstrated that the free thyroxine values were strongly influenced by the concentration of thyroxine binding globulin in the samples. The standard curve could no longer be distinguished at a concentration of purified thyroxine binding globulin of 52 mg/1.
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Materials and Methods

Experimental procedures
Preparation of thyroxine binding globulin
Highly purified thyroxine binding globulin was prepared from pooled human serum by affinity chromatography as previously described (8) . The technique employed was essentially that described by Pensky & Marchall (9) . [ 125 I]Thyroxine was added to the purified material and the mixture subjected to disc electrophoresis. The single band of stained protein coincided with the single peak of radioactivity. The thyroxine binding globulin did not contain any thyroxine (T 4 ) after purification.
Assay procedures
The assay for FT 4 .0 and 64.5 pmol/1) were pipetted into correspondingly labelled tubes and each tube was vortexed for 4 seconds. The tubes were subsequently incubated in a water bath at 37 °C for 2 hours. After one hour, all the tubes were vortexed for a further 4 seconds and then returned to the incubator. After incubation, 1 ml of wash solution (polyethylenimine) was added to each tube, which was then vortexed for a further 4 seconds. The tubes were incubated at room temperature for 20 minutes, centrifuged at 1400 g for 10 minutes, then decanted. The microcapsules were counted in a gamma counter for 1 minute. In the range 5.16 -58.1 pmol/1, the intra-assay coefficient of variation was 7.2 -8.5%. In the range 12.9 -38.7 pmol/1, the inter-assay coefficient of variation was 14.7 -15.9%. FT 4 was also measured using the Amerlex kit (Amersham, U. K.); triiodothyronine, thyroxine, thyrotropin, thyroglobulin and thyroxine binding globulin were measured with the EIKEN kit (EIKEN ICL, Japan), and T 3 uptake (T 3 U) was measured with the Dainabot kit (Dainabot, Japan). The accuracy of these kits and the analytical procedures for measurement of these hormones have previously been described in detail (7) . All samples were measured simultaneously in order to avoid inter-assay variations. The results are expressed as the mean ± standard deviation (SD).
Subjects
Thyroid function studies were performed on 156 normal adult subjects, 106 pregnant women (30 subjects, 0 -10 weeks; 22 subjects, 11-20 weeks; 24 subjects, 21 -30 weeks; 30 subjects, 31-40 weeks), 26 hyperthyroid patients and 29 primary hypothyroid patients with detectable thyroxine (12.9 -51.6 nmol/1). In addition, 16 patients with severe primary hypothyroidism with negligible thyroxine (less than 12.9 nmol/1) and 17 patients receiving triiodothyronine treatment after total thyroidectomy (thyroxine less than 12.9 nmol/1) were studied. Sera were aliquoted and stored at -20 °C until the assay.
Results
The effect of different concentrations (0 -52 mg/1) of purified thyroxine binding globulin on the microencapsulated antibody method is shown in figure 1 . Four test tubes were prepared, each containing 500 μΐ of microcapsule suspension. To the first was added 25 μΐ of serum containing no thyroxine binding globulin; to the second, 25 μΐ of serum containing 13 mg/1 of purified thyroxine binding globulin; and to the A further examination of the Liquisol kit was undertaken as a clinical study. Table 1 shows the circulating FT 4 levels determined by the Amerlex kit and Liquisol kit in healthy normal subjects, pregnant women, patients with hyperthyroidism, and with primary hypothyroidism with detectable thyroxine. As shown in the table, the values obtained using the Liquisol kit were always higher (P < 0.001) than those from the 
Discussion
Numerous commercial methods are now available for the measurement of FT 4 . Some claim that an accurate, precise assay of FT 4 provides the single best assessment of thyroid function (10, 11) . Unfortunately, as with all clinical laboratory methods, FT 4 methods suffer from interferences. The most common is the effect of abnormal albumin concentrations (12, 13) or non-esterified fatty acids (14, 15) . Since each FT 4 method behaves uniquely, each should be independently viewed with respect to interference. Common interferences (albumin effect, non-esterified fatty acid effect) have been thoroughly studied, but the effect of unsaturated thyroxine binding globulin has not yet been investigated, although it has been suspected that the performance of DPC kits (Diagnostic Products Corp., USA) is dependent on the concentration of thyroxine binding globulin in serum (16) .
As shown in figure 1 , the addition increasing amounts of purified thyroxine binding globulin to a test tube containing microcapsule suspension strongly affected the accuracy of the results. We found that in the presence of rather high amounts of thyroxine binding globulin, [ Melmed et al. (3) also reported erroneously high FT 4 levels in patients with primary hypothyroidism using the Liquisol kit. However, at that time, they did not investigate the reason for these high levels.
Theoretically, FT 4 levels in patients receiving triiodothyronine treatment after total thyroidectomy should be nil. The reason for these false positive values may lie in a methodological problem of the Liquisol kit, which relies on FT 4 moving through the microcapsule membrane. The possibility that the Liquisol kit was not properly calibrated to zero, was disproved, since it was shown that the zero serum of the Liquisol FT 4 kit was undetectable by Amerlex FT 4 radioimmunoassay.
In 1983, we put forward the hypothesis that the artificially high results obtained with the Liquisol kit are due to the leakage of 125 I from the microcapsule (7). This hypothesis has been validated by the experiment described in this paper. To avoid erroneous interpretations, we would therefore advise caution, especially when the results obtained with the Liquisol kit are used as a test for patients with primary hypothyroidism, since in these cases the thyroxine binding globulin concentration is usually increased (17) .
